Article info
PDFClinical science
Original article
Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction
- Correspondence to Dr Carol L Shields, Ocular Oncology Service, Suite 1440, Wills Eye Institute, 840 Walnut Street, Philadelphia, PA 19107, USA; carol.shields{at}shieldsoncology.com
Citation
Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction
Publication history
- Accepted May 4, 2011
- First published June 7, 2011.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.